MALLIKARJUNARAO GANESANA

Dr. MALLIKARJUNARAO GANESANA

orcid

Research Focus & Metrics

Representative Publications

View All Publications
4 October 2018 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
CYCheng Yang
Cheng Yang
QCQun Cao
Qun Cao
PPPumidech Puthongkham
Pumidech Puthongkham
SLScott T. Lee
Scott T. Lee
MGMALLIKARJUNARAO GANESANA
MALLIKARJUNARAO GANESANA
BVB. Jill Venton
B. Jill Venton

3 October 2019 in Biomolecules
Verified
Journal Article
Open access
PDF file
AEAna Estevez
Ana Estevez
MGMALLIKARJUNARAO GANESANA
MALLIKARJUNARAO GANESANA
JTJohn F. Trentini
John F. Trentini
JOJames Olson
James Olson
GLGuangze Li
Guangze Li
Joseph  ErlichmanJoseph Erlichman
Joseph Erlichman
Cerium oxide (CeO2) nanoparticles (CeNPs) are potent antioxidants that are being explored as potential therapies for diseases in which oxidative stress plays an important pathological role. However, both beneficial and toxic effects of CeNPs have been reported, and the method of synthesis as well as physico-chemical, biological, and environmental factors can impact the ultimate biological effects of CeNPs. In the present study, we explored the effect of different ratios of citric acid (CA) and EDTA (CA/EDTA), which are used as stabilizers during synthesis of CeNPs, on the antioxidant enzyme-mimetic and biological activity of the CeNPs. We separated the CeNPs into supernatant and pellet fractions and used commercially available enzymatic assays to measure the catalase-, superoxide dismutase (SOD)-, and oxidase-mimetic activity of each fraction. We tested the effects of these CeNPs in a mouse hippocampal brain slice model of ischemia to induce oxidative stress where the fluorescence indicator SYTOX green was used to assess cell death. Our results demonstrate that CeNPs stabilized with various ratios of CA/EDTA display different enzyme-mimetic activities. CeNPs with intermediate CA/EDTA stabilization ratios demonstrated greater neuroprotection in ischemic mouse brain slices, and the neuroprotective activity resides in the pellet fraction of the CeNPs. The neuroprotective effects of CeNPs stabilized with equal proportions of CA/EDTA (50/50) were also demonstrated in two other models of ischemia/reperfusion in mice and rats. Thus, CeNPs merit further development as a neuroprotective therapy for use in diseases associated with oxidative stress in the nervous system.

4 October 2018 in Angewandte Chemie
Verified
Journal Article
Closed access
PDF file
CYCheng Yang
Cheng Yang
QCQun Cao
Qun Cao
PPPumidech Puthongkham
Pumidech Puthongkham
SLScott T. Lee
Scott T. Lee
MGMALLIKARJUNARAO GANESANA
MALLIKARJUNARAO GANESANA
BVB. Jill Venton
B. Jill Venton

4 February 2025 in Journal of Neurochemistry
Verified
Journal Article
Open access
GOGreatness Olaitan
Greatness Olaitan
MGMALLIKARJUNARAO GANESANA
MALLIKARJUNARAO GANESANA
ASAndrew Strohman
Andrew Strohman
WLWendy J. Lynch
Wendy J. Lynch
WLWynn Legon
Wynn Legon
BVB. Jill Venton
B. Jill Venton
Dopamine is a neurotransmitter that plays a significant role in reward and motivation. Dysfunction in the mesolimbic dopamine pathway has been linked to a variety of psychiatric disorders, including addiction. Low‐intensity focused ultrasound (LIFU) has demonstrated effects on brain activity, but how LIFU affects dopamine neurotransmission is not known. Here, we applied three different intensities (6.5, 13, and 26 W/cm 2 I SPPA ) of 2‐min LIFU to the prelimbic cortex (PLC) and measured dopamine in the nucleus accumbens (NAc) core using fast‐scan cyclic voltammetry. Two minutes of LIFU sonication at 13 W/cm 2 to the PLC significantly reduced dopamine release by ~50% for up to 2 h. However, double the intensity (26 W/cm 2 ) resulted in less inhibition (~30%), and half the intensity (6.5 W/cm 2 ) did not result in any inhibition of dopamine. Anatomical controls applying LIFU to the primary somatosensory cortex did not change NAc core dopamine, and applying LIFU to the PLC did not affect dopamine release in the caudate or NAc shell. Histological evaluations showed no evidence of cell damage or death. Modeling temperature rise demonstrates a maximum temperature change of 0.5°C with 13 W/cm 2 , suggesting that modulation is not due to thermal mechanisms. These studies show that LIFU at a moderate intensity provides a noninvasive, high spatial resolution means to modulate specific mesolimbic circuits that could be used in future studies to target and repair pathways that are dysfunctional in addiction and other psychiatric diseases. image

14 February 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
GOGreatness O. Olaitan
Greatness O. Olaitan
MGMALLIKARJUNARAO GANESANA
MALLIKARJUNARAO GANESANA
ASAndrew Strohman
Andrew Strohman
WLWendy J. Lynch
Wendy J. Lynch
WLWynn Legon
Wynn Legon
BVB. Jill Venton
B. Jill Venton
Dopamine is a neurotransmitter that plays a significant role in reward and motivation. Dysfunction in the mesolimbic dopamine pathway has been linked to a variety of psychiatric disorders, including addiction. Low-intensity focused ultrasound (LIFU) has demonstrated effects on brain activity, but how LIFU affects dopamine neurotransmission is not known. Here, we applied three different intensities (6.5, 13, and 26 W/cm 2 I sppa ) of 2-minute LIFU to the prelimbic region (PLC) and measured dopamine in the nucleus accumbens (NAc) core using fast-scan cyclic voltammetry. Two minutes of LIFU sonication at 13 W/cm 2 to the PLC significantly reduced dopamine release by ∼ 50% for up to 2 hours. However, double the intensity (26 W/cm 2 ) resulted in less inhibition (∼30%), and half the intensity (6.5 W/cm 2 ) did not result in any inhibition of dopamine. Anatomical controls applying LIFU to the primary somatosensory cortex did not change NAc core dopamine, and applying LIFU to the PLC did not affect dopamine release in the caudate or NAc shell. Histological evaluations showed no evidence of cell damage or death. Modeling of temperature rise demonstrates a maximum temperature change of 0.5°C with 13 W/cm 2 , suggesting that modulation is not due to thermal mechanisms. These studies show that LIFU at a moderate intensity provides a noninvasive, high spatial resolution means to modulate specific mesolimbic circuits that could be used in future studies to target and repair pathways that are dysfunctional in addiction and other psychiatric diseases.